# Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI

Study · id `cardio:ct-nct02859480` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02859480](<https://clinicaltrials.gov/study/NCT02859480>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02859480

Browse, organ or system: Heart; Blood vessels; Metabolism  
Browse, condition area: Risk and prevention; Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT02859480. Randomized; no masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2019-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT02859480, source copy `cardio:ctgov-nct02859480-2016-08-09`, retrieved 2026-10-26)
- Start date: 2015-09 (registry gives no type) (ClinicalTrials.gov record NCT02859480, source copy `cardio:ctgov-nct02859480-2016-08-09`, retrieved 2026-10-26)
- Primary completion: 2019-06 (anticipated) (ClinicalTrials.gov record NCT02859480, source copy `cardio:ctgov-nct02859480-2016-08-09`, retrieved 2026-10-26)
- Completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT02859480, source copy `cardio:ctgov-nct02859480-2016-08-09`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02859480, source copy `cardio:ctgov-nct02859480-2016-08-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02859480-2016-08-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
- Acronym: ROSUVA-30
- Condition: Coronary Artery Disease
- Condition: Coronary Disease
- Condition: Cardiovascular Diseases
- Intervention (Drug): Rosuvastatin 5mg
- Intervention (Drug): Rosuvastatin 20mg
- Lead sponsor: Korea University Anam Hospital
- Lead sponsor class: OTHER
- Collaborator: Samjin Pharmaceutical Co., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Korea University Anam Hospital (`cardio:org-korea-university-anam-hospital`)
- Registry lists this organization as a collaborator: Samjin Pharmaceutical Co., Ltd. (`cardio:org-samjin-pharmaceutical-co-ltd`)

## Provenance

Content hash: 784781d0d6d4858b2266eadb492fd40ea3e3890b843676bfc22b110b9e4f3828
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
